Marı́a Varela

机构：Universidad de Oviedo, Hospital Universitario Central de Asturias · ORCID：0000-0003-4288-2593

发表论文 217 篇 · 总被引 8140 次 · h-index 33

代表论文

• Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC (2025 · Journal of Hepatology · 被引 155)
• Evolving epidemiology of HCC in Spain (2025 · JHEP Reports · 被引 8)
• Breaking Barriers for Intensive Care Admission in Patients With Advanced HCC on Immunotherapy (2025 · Liver International · 被引 7)
• Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second‐Line (The GOING Trial) (2026 · Alimentary Pharmacology & Therapeutics · 被引 4)
• Cardiological adverse events in hepatocellular carcinoma patients receiving immunotherapy: Influence of comorbidities and clinical outcomes (2025 · European Journal of Cancer · 被引 4)
• Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial (2025 · Journal of Patient-Reported Outcomes · 被引 3)